🕵️ Relmada Therapeutics, Inc. ($RLMD)
SEC insider & ownership activity, last 12 months · CIK 1553643 · every row links its SEC filing
Over the last 12 months insiders bought $2.5M with no open-market selling against it. Shenouda Maged bought $1.1M in discretionary trades (Nov–Dec). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $2.5M (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Shenouda Maged | 2 | $1.1M | 0 | – | Dec 15, 2025 |
| Traversa Sergio | 5 | $891K | 0 | – | Dec 15, 2025 |
| Ence Chuck | 1 | $299K | 0 | – | Nov 5, 2025 |
| Kelly Paul Edward | 1 | $198K | 0 | – | Nov 5, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Janus Henderson Group PLC | 10.1% | 13G | Feb 6, 2026 | filing ↗ | |
| Squadron Master Fund LP | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Squadron Capital Management LLC | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| William Blank | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Matthew Sesterhenn | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners III, L.P. | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| VHCP Management III, LLC | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| VHCP Management EG, LLC | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| Nimish Shah | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| Bong Y. Koh | 6.2% | 13G | Jun 9, 2026 | filing ↗ | |
| Spruce Street Capital LP | 5.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Alex R. Rosen | 5.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Simon Basseyn | 5.6% | 13G | Feb 17, 2026 | filing ↗ | |
| Commodore Capital LP | 5.1% | 13G | May 4, 2026 | filing ↗ | |
| Commodore Capital Master LP | 5.1% | 13G | May 4, 2026 | filing ↗ | |
| Robert Egen Atkinson | 5.1% | 13G | May 4, 2026 | filing ↗ | |
| Michael Kramarz | 5.1% | 13G | May 4, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 28, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Earnings (2.02) | Mar 19, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 19, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 9, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 9, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 9, 2026 | filing ↗ |
| Other events (8.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 4, 2025 | filing ↗ |
| Other events (8.01) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 17, 2025 | filing ↗ |
| Other events (8.01) | Sep 15, 2025 | filing ↗ |